|
Volumn 855, Issue 1 SPEC. ISS., 2007, Pages 66-70
|
Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab)
|
Author keywords
Electrophoresis; Infliximab; Matrix assisted laser desorption ionization time of flight mass spectrometry; Rheumatoid arthritis; Tumor necrosis factor
|
Indexed keywords
ELECTROPHORESIS;
GELS;
MASS SPECTROMETRY;
PROTEINS;
TUMORS;
RHEUMATOID ARTHRITIS;
SERUM PROTEIN;
STAINING INTENSITY;
TRANSTHYRETIN;
PATIENT TREATMENT;
ANTIOXIDANT;
APOLIPOPROTEIN A1;
C REACTIVE PROTEIN;
CLUSTERIN;
COMPLEMENT COMPONENT C3;
DICLOFENAC;
ETODOLAC;
INFLIXIMAB;
LIPID;
LOXOPROFEN;
METHOTREXATE;
PLASMA PROTEIN;
PREALBUMIN;
PREDNISOLONE;
RETINOL BINDING PROTEIN;
SALAZOSULFAPYRIDINE;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
FEMALE;
HUMAN;
LIPID BLOOD LEVEL;
MALE;
MASS SPECTROMETRY;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN MODIFICATION;
PROTEOMICS;
RHEUMATOID ARTHRITIS;
STAINING;
TWO DIMENSIONAL GEL ELECTROPHORESIS;
|
EID: 34447578027
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2007.02.028 Document Type: Article |
Times cited : (11)
|
References (20)
|